(CHD) Church & Dwight - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1713401024

Baking Soda, Laundry Detergent, Toothbrush, Pregnancy Test, Condom

Household Products
Market Cap in USD: 20,897m

IPO / Inception: 1986-03-06
12m vs SPY: -28.3%

EPS (Earnings per Share)

EPS CAGR: 6.48%
EPS Trend: -3.7%

Last SUE: 0.19
Qual. Beats: 0

Revenue

Rev. CAGR: 4.00%
Rev. Trend: 86.7%

Last SUE: 2.21
Qual. Beats: 1

Dividends

Dividend Yield	1.26%
Yield on Cost 5y	1.48%
Yield CAGR 5y	3.91%
Payout Consistency	92.1%
Payout Ratio	34.4%

Risk via 5d forecast
Volatility	19.2%
Value at Risk 5%th	32.4%
Relative Tail Risk	2.69%

Reward TTM
Sharpe Ratio	-0.71
Alpha	-16.93
CAGR/Max DD	0.13

Character TTM
Hurst Exponent	0.521
Beta	0.040
Beta Downside	0.036

Drawdowns 3y
Max DD	27.28%
Mean DD	7.67%
Median DD	5.30%

Description: CHD Church & Dwight December 19, 2025

Church & Dwight Co. (NYSE: CHD) is a diversified consumer-goods company that develops, manufactures, and markets a broad portfolio of household, personal-care, and specialty products across three segments: Consumer Domestic, Consumer International, and Specialty Products. Its flagship brands include ARM & HAMMER (baking-soda-based cleaners, cat litter, and feed additives), TROJAN (condoms and lubricants), OXICLEAN (stain-removers and bleach alternatives), SPINBRUSH (toothbrushes), FIRST RESPONSE (pregnancy/ovulation tests), NAIR (depilatories), and a suite of niche offerings such as WATERPIK (water flossers) and ZICAM (cold-relief medicines).

In FY 2023 the company reported net sales of roughly **$5.3 billion**, an adjusted earnings-per-share of **$2.15**, and an operating margin of **≈13 %**. CHD paid a quarterly dividend of **$0.45**, yielding about **3.2 %** on its current price, and has raised the dividend for 15 consecutive years, underscoring its cash-flow stability.

Key drivers of CHD’s performance include: (1) **Consumer-staples resilience** – even in a tightening economy, demand for cleaning and personal-care essentials remains relatively inelastic; (2) **Input-cost volatility** – prices for soda ash, surfactants, and other chemicals can compress margins, making the firm’s long-term supply contracts a material risk factor; and (3) **E-commerce penetration** – online sales now account for roughly **12 %** of total revenue, accelerating growth in higher-margin private-label and direct-to-consumer channels.

For a deeper, data-driven look at CHD’s valuation metrics and scenario analysis, you may find the research tools on ValueRay useful.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (782.5m TTM) > 0 and > 6% of Revenue (6% = 368.5m TTM)

FCFTA 0.11 (>2.0%) and ΔFCFTA 1.12pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 2.11% (prev 12.72%; Δ -10.61pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.13 (>3.0%) and CFO 1.14b > Net Income 782.5m (YES >=105%, WARN >=100%)

Net Debt (2.07b) to EBITDA (1.39b) ratio: 1.49 <= 3.0 (WARN <= 3.5)

Current Ratio 1.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (245.9m) change vs 12m ago 0.53% (target <= -2.0% for YES)

Gross Margin 44.44% (prev 45.65%; Δ -1.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 68.96% (prev 69.85%; Δ -0.89pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 9.73 (EBITDA TTM 1.39b / Interest Expense TTM 117.0m) >= 6 (WARN >= 3)

Altman Z'' 4.83

(A) 0.01 = (Total Current Assets 1.63b - Total Current Liabilities 1.50b) / Total Assets 9.14b

(B) 0.73 = Retained Earnings (Balance) 6.70b / Total Assets 9.14b

(D) 1.42 = Book Value of Equity 6.97b / Total Liabilities 4.92b

Total Rating: 4.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 78.18

1. Piotroski 6.0pt

2. FCF Yield 4.45%

3. FCF Margin 16.65%

4. Debt/Equity 0.56

5. Debt/Ebitda 1.49

6. ROIC - WACC (= 7.74)%

7. RoE 17.86%

8. Rev. Trend 86.66%

9. EPS Trend -3.71%

What is the price of CHD shares?

As of January 14, 2026, the stock is trading at USD 87.97 with a total of 3,343,408 shares traded.
Over the past week, the price has changed by +2.86%, over one month by +3.48%, over three months by +2.03% and over the past year by -13.39%.

Is CHD a buy, sell or hold?

Church & Dwight has received a consensus analysts rating of 3.42. Therefor, it is recommend to hold CHD.

Strong Buy: 7
Buy: 2
Hold: 10
Sell: 4
Strong Sell: 1

What are the forecasts/targets for the CHD price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	95.9	9%
Analysts Target Price	95.9	9%
ValueRay Target Price	86.3	-1.9%

CHD Fundamental Data Overview January 11, 2026

P/E Trailing = 27.0599
P/E Forward = 22.779
P/S = 3.4028
P/B = 4.8822
P/EG = 1.9804
Beta = 0.46
Revenue TTM = 6.14b USD
EBIT TTM = 1.14b USD
EBITDA TTM = 1.39b USD
Long Term Debt = 2.20b USD (from longTermDebt, last quarter)
Short Term Debt = 32.4m USD (from shortTermDebt, last fiscal year)
Debt = 2.37b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.07b USD (from netDebt column, last quarter)
Enterprise Value = 22.96b USD (20.90b + Debt 2.37b - CCE 305.3m)
Interest Coverage Ratio = 9.73 (Ebit TTM 1.14b / Interest Expense TTM 117.0m)
EV/FCF = 22.46x (Enterprise Value 22.96b / FCF TTM 1.02b)
FCF Yield = 4.45% (FCF TTM 1.02b / Enterprise Value 22.96b)
FCF Margin = 16.65% (FCF TTM 1.02b / Revenue TTM 6.14b)
Net Margin = 12.74% (Net Income TTM 782.5m / Revenue TTM 6.14b)
Gross Margin = 44.44% ((Revenue TTM 6.14b - Cost of Revenue TTM 3.41b) / Revenue TTM)
Gross Margin QoQ = 45.06% (prev 42.95%)
Tobins Q-Ratio = 2.51 (Enterprise Value 22.96b / Total Assets 9.14b)
Interest Expense / Debt = 1.97% (Interest Expense 46.8m / Debt 2.37b)
Taxrate = 22.86% (54.0m / 236.2m)
NOPAT = 878.5m (EBIT 1.14b * (1 - 22.86%))
Current Ratio = 1.09 (Total Current Assets 1.63b / Total Current Liabilities 1.50b)
Debt / Equity = 0.56 (Debt 2.37b / totalStockholderEquity, last quarter 4.22b)
Debt / EBITDA = 1.49 (Net Debt 2.07b / EBITDA 1.39b)
Debt / FCF = 2.02 (Net Debt 2.07b / FCF TTM 1.02b)
Total Stockholder Equity = 4.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.79% (Net Income 782.5m / Total Assets 9.14b)
RoE = 17.86% (Net Income TTM 782.5m / Total Stockholder Equity 4.38b)
RoCE = 17.29% (EBIT 1.14b / Capital Employed (Equity 4.38b + L.T.Debt 2.20b))
RoIC = 13.34% (NOPAT 878.5m / Invested Capital 6.59b)
WACC = 5.60% (E(20.90b)/V(23.27b) * Re(6.06%) + D(2.37b)/V(23.27b) * Rd(1.97%) * (1-Tc(0.23)))
Discount Rate = 6.06% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.22%
[DCF Debug] Terminal Value 87.08% ; FCFF base≈962.4m ; Y1≈1.04b ; Y5≈1.29b
Fair Price DCF = 150.1 (EV 38.10b - Net Debt 2.07b = Equity 36.03b / Shares 240.1m; r=5.90% [WACC]; 5y FCF grow 9.21% → 2.90% )
EPS Correlation: -3.71 | EPS CAGR: 6.48% | SUE: 0.19 | # QB: 0
Revenue Correlation: 86.66 | Revenue CAGR: 4.00% | SUE: 2.21 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.97 | Chg30d=+0.002 | Revisions Net=-2 | Analysts=13
EPS next Year (2026-12-31): EPS=3.74 | Chg30d=-0.005 | Revisions Net=-3 | Growth EPS=+7.3% | Growth Revenue=+3.3%

Additional Sources for CHD Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle